The lncRNA TRG-AS1 promotes the growth of colorectal cancer cells through the regulation of P2RY10/GNA13

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi: 10.3322/caac.21708.
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Ciardiello D, Martini G, et al. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin. 2022;72(4):372–401. doi: 10.3322/caac.21728.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Fu Y, Wang P-P, et al. Neoantigen: a promising target for the immunotherapy of colorectal cancer. Dis Markers. 2022;2022:8270305–8270311.
   PubMed Web of Science ®Google Scholar
• Weng J, Li S, Zhu Z, et al. Exploring immunotherapy in colorectal cancer. J Hematol Oncol. 2022;15(1):95. doi: 10.1186/s13045-022-01294-4.
   PubMed Web of Science ®Google Scholar
• Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019;16(6):361–375. doi: 10.1038/s41575-019-0126-x.
   PubMed Web of Science ®Google Scholar
• Jia W, Zhang T, Huang H, et al. Colorectal cancer vaccines: the current scenario and future prospects. Front Immunol. 2022;13:942235. doi: 10.3389/fimmu.2022.942235.
   PubMed Web of Science ®Google Scholar
• Venderbosch S, Nagtegaal ID, Maughan TS, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res. 2014;20(20):5322–5330. doi: 10.1158/1078-0432.CCR-14-0332.
   PubMed Web of Science ®Google Scholar
• André T, de Gramont A, Vernerey D, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III Colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol. 2015;33(35):4176–4187. doi: 10.1200/JCO.2015.63.4238.
   PubMed Web of Science ®Google Scholar
• Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625–639. doi: 10.1042/EBC20200032.
   PubMed Web of Science ®Google Scholar
• Zhang W, Guan X, Tang J. The long non-coding RNA landscape in triple-negative breast cancer. Cell Prolif. 2021;54(2):e12966.
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, et al. Long Non-Coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015. doi: 10.3390/cells8091015.
   PubMed Web of Science ®Google Scholar
• Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 2017;15(3):177–186. doi: 10.1016/j.gpb.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Zhuang L, Ding W, Ding W, et al. lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression. J Cell Physiol. 2021;236(3):2178–2193. doi: 10.1002/jcp.30004.
   PubMed Web of Science ®Google Scholar
• Cao R, Cui L, Zhang J, et al. Immune-related lncRNA classification of head and neck squamous cell carcinoma. Cancer Cell Int. 2022;22(1):25. doi: 10.1186/s12935-022-02450-z.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu W, Haeryfar M, et al. Long Non-Coding RNA TRG-AS1 promoted proliferation and invasion of lung cancer cells through the miR-224-5p/SMAD4 axis. Onco Targets Ther. 2021;14:4415–4426. doi: 10.2147/OTT.S297336.
   PubMed Web of Science ®Google Scholar
• Wang LX, Li Y, Chen GZ. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma. PLoS One. 2018;13(1):e0190447. doi: 10.1371/journal.pone.0190447.
   PubMed Web of Science ®Google Scholar
• Otake-Kasamoto Y, et al. Lysophosphatidylserines derived from microbiota in crohn’s disease elicit pathological Th1 response. J Exp Med. 2022;219(7):e20211291. doi: 10.1084/jem.20211291.
   PubMed Web of Science ®Google Scholar
• Guo P, Tai Y, Wang M, et al. Gα(12) and Gα(13): versatility in physiology and pathology. Front Cell Dev Biol. 2022;10:809425. doi: 10.3389/fcell.2022.809425.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Lin Y, et al. MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer. Am J Transl Res. 2017;9(2):466–477.
   PubMed Web of Science ®Google Scholar
• Fan A, Wang B, Wang X, et al. Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci. 2021;17(14):3837–3849. doi: 10.7150/ijbs.64077.
   PubMed Web of Science ®Google Scholar
• Wang L, et al. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20(22):5758. doi: 10.3390/ijms20225758.
   Web of Science ®Google Scholar
• Wang Y, Lu J-H, Wu Q-N, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18(1):174. doi: 10.1186/s12943-019-1105-0.
   PubMed Web of Science ®Google Scholar
• Zhang M, Weng W, Zhang Q, et al. The lncRNA NEAT1 activates wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol. 2018;11(1):113. doi: 10.1186/s13045-018-0656-7.
   PubMed Web of Science ®Google Scholar
• Zheng J, et al. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment. J Clin Lab Anal. 2021;35(11):e23951.
   PubMed Web of Science ®Google Scholar
• Ma R, Guan X, Teng N, et al. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer. BMC Med Genomics. 2023;16(1):254. doi: 10.1186/s12920-023-01683-9.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang X, Dong L, et al. Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers. Sci Data. 2023;10(1):663. doi: 10.1038/s41597-023-02550-z.
   PubMed Web of Science ®Google Scholar
• Xu Z, Pan B, Li Y, et al. Identification and validation of Ferroptosis-Related LncRNAs signature as a novel prognostic model for chronic lymphocytic leukemia. Int J Gen Med. 2023;16:1541–1553. doi: 10.2147/IJGM.S399629.
   PubMed Web of Science ®Google Scholar
• Rothzerg E, Ho XD, Xu J, et al. Upregulation of 15 antisense long Non-Coding RNAs in osteosarcoma. Genes (Basel). 2021;12(8):1132. doi: 10.3390/genes12081132.
   PubMed Web of Science ®Google Scholar
• Sun X, Qian Y, Wang X, et al. LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1. Cancer Cell Int. 2020;20(1):367. doi: 10.1186/s12935-020-01440-3.
   PubMed Web of Science ®Google Scholar
• Xie H, Shi S, Chen Q, et al. LncRNA TRG-AS1 promotes glioblastoma cell proliferation by competitively binding with miR-877-5p to regulate SUZ12 expression. Pathol Res Pract. 2019;215(8):152476. doi: 10.1016/j.prp.2019.152476.
   PubMed Web of Science ®Google Scholar
• Bueno-Urquiza LJ, Martínez-Barajas MG, Villegas-Mercado CE, et al. The two faces of immune-related lncRNAs in head and neck squamous cell carcinoma. Cells. 2023;12(5):727. doi: 10.3390/cells12050727.
   PubMed Web of Science ®Google Scholar
• Bongers BJ, Gorostiola González M, Wang X, et al. Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors. Sci Rep. 2022;12(1):21534. doi: 10.1038/s41598-022-25323-x.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y-F, Nanayakkara G, et al. Lysophospholipid receptors, as novel conditional danger receptors and homeostatic receptors modulate Inflammation-Novel paradigm and therapeutic potential. J Cardiovasc Transl Res. 2016;9(4):343–359. doi: 10.1007/s12265-016-9700-6.
   PubMed Web of Science ®Google Scholar
• Li Y, Lyu S, Gao Z, et al. Identification of potential prognostic biomarkers associated with cancerometastasis in skin cutaneous melanoma. Front Genet. 2021;12:687979. doi: 10.3389/fgene.2021.687979.
   PubMedGoogle Scholar
• Wang S, Zheng X, Chen X, et al. Prognostic and predictive value of immune/stromal-related gene biomarkers in renal cell carcinoma. Oncol Lett. 2020;20(1):308–316. doi: 10.3892/ol.2020.11574.
   Web of Science ®Google Scholar
• Kihara Y, Maceyka M, Spiegel S, et al. Lysophospholipid receptor nomenclature review: IUPHAR review 8. Br J Pharmacol. 2014;171(15):3575–3594. doi: 10.1111/bph.12678.
   PubMed Web of Science ®Google Scholar
• Rasheed SAK, Subramanyan LV, Lim WK, et al. The emerging roles of Gα12/13 proteins on the hallmarks of cancer in solid tumors. Oncogene. 2022;41(2):147–158. doi: 10.1038/s41388-021-02069-w.
   PubMed Web of Science ®Google Scholar
• Udayappan UK, Casey PJ. C-Jun contributes to transcriptional control of GNA12 expression in prostate cancer cells. Molecules. 2017;22(4):22. doi: 10.3390/molecules22040612.
   Web of Science ®Google Scholar
• Ha J-H, Jayaraman M, Yan M, et al. Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer. Oncol Lett. 2021;22(4):719. doi: 10.3892/ol.2021.12980.
   PubMed Web of Science ®Google Scholar
• Zhang JX, Mai SJ, Huang XX, et al. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Ann Oncol. 2014;25(11):2196–2204. doi: 10.1093/annonc/mdu439.
   PubMed Web of Science ®Google Scholar
• Sivaraj KK, Takefuji M, Schmidt I, et al. G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev Cell. 2013;25(4):427–434. doi: 10.1016/j.devcel.2013.04.008.
   PubMed Web of Science ®Google Scholar
• Zhang J-X, Yun M, Xu Y, et al. GNA13 as a prognostic factor and mediator of gastric cancer progression. Oncotarget. 2016;7(4):4414–4427. doi: 10.18632/oncotarget.6780.
   PubMedGoogle Scholar
• Rasheed SAK, Teo CR, Beillard EJ, et al. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J Biol Chem. 2013;288(11):7986–7995. doi: 10.1074/jbc.M112.437749.
   PubMed Web of Science ®Google Scholar